全文获取类型
收费全文 | 340827篇 |
免费 | 23063篇 |
国内免费 | 7355篇 |
专业分类
耳鼻咽喉 | 4118篇 |
儿科学 | 9542篇 |
妇产科学 | 6663篇 |
基础医学 | 27227篇 |
口腔科学 | 8005篇 |
临床医学 | 39871篇 |
内科学 | 41848篇 |
皮肤病学 | 4635篇 |
神经病学 | 19334篇 |
特种医学 | 7872篇 |
外国民族医学 | 32篇 |
外科学 | 37411篇 |
综合类 | 50898篇 |
现状与发展 | 12篇 |
一般理论 | 29篇 |
预防医学 | 34397篇 |
眼科学 | 5204篇 |
药学 | 29984篇 |
372篇 | |
中国医学 | 30369篇 |
肿瘤学 | 13422篇 |
出版年
2023年 | 5596篇 |
2022年 | 8916篇 |
2021年 | 13724篇 |
2020年 | 12815篇 |
2019年 | 18631篇 |
2018年 | 15967篇 |
2017年 | 13002篇 |
2016年 | 10371篇 |
2015年 | 9572篇 |
2014年 | 19823篇 |
2013年 | 21414篇 |
2012年 | 18270篇 |
2011年 | 19729篇 |
2010年 | 15865篇 |
2009年 | 14553篇 |
2008年 | 14155篇 |
2007年 | 14629篇 |
2006年 | 12734篇 |
2005年 | 11074篇 |
2004年 | 9005篇 |
2003年 | 7939篇 |
2002年 | 6228篇 |
2001年 | 5603篇 |
2000年 | 4595篇 |
1999年 | 3965篇 |
1998年 | 3041篇 |
1997年 | 2893篇 |
1996年 | 2499篇 |
1995年 | 2573篇 |
1994年 | 2490篇 |
1993年 | 1978篇 |
1992年 | 2013篇 |
1991年 | 1751篇 |
1990年 | 1571篇 |
1989年 | 1401篇 |
1988年 | 1313篇 |
1987年 | 1130篇 |
1985年 | 3788篇 |
1984年 | 4797篇 |
1983年 | 3351篇 |
1982年 | 3806篇 |
1981年 | 3554篇 |
1980年 | 3158篇 |
1979年 | 2907篇 |
1978年 | 2534篇 |
1977年 | 1908篇 |
1976年 | 2150篇 |
1975年 | 1632篇 |
1974年 | 1429篇 |
1973年 | 1278篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
21.
《The Journal of thoracic and cardiovascular surgery》2023,165(2):591-604.e3
ObjectivesGuidelines suggest aortic valve replacement (AVR) for low-risk asymptomatic patients. Indications for transcatheter AVR now include low-risk patients, making it imperative to understand state-of-the-art surgical AVR (SAVR) in this population. Therefore, we compared SAVR outcomes in low-risk patients with those expected from Society of Thoracic Surgeons (STS) models and assessed their intermediate-term survival.MethodsFrom January 2005 to January 2017, 3493 isolated SAVRs were performed in 3474 patients with STS predicted risk of mortality <4%. Observed operative mortality and composite major morbidity or mortality were compared with STS-expected outcomes according to calendar year of surgery. Logistic regression analysis was used to identify risk factors for these outcomes. Patients were followed for time-related mortality.ResultsWith 15 observed operative deaths (0.43%) compared with 55 expected (1.6%), the observed:expected ratio was 0.27 for mortality (95% confidence interval [CI], 0.14-0.42), stroke 0.65 (95% CI, 0.41-0.89), and reoperation 0.50 (95% CI, 0.42-0.60). Major morbidity or mortality steadily declined, with probabilities of 8.6%, 6.7%, and 5.2% in 2006, 2011, and 2016, respectively, while STS-expected risk remained at approximately 12%. Mitral valve regurgitation, ventricular hypertrophy, pulmonary, renal, and hepatic failure, coronary artery disease, and earlier surgery date were residual risk factors. Survival was 98%, 91%, and 82% at 1, 5, and 9 years, respectively, superior to that predicted for the US age-race-sex–matched population.ConclusionsSTS risk models overestimate contemporary SAVR risk at a high-volume center, supporting efforts to create a more agile quality assessment program. SAVR in low-risk patients provides durable survival benefit, supporting early surgery and providing a benchmark for transcatheter AVR. 相似文献
22.
《The Annals of thoracic surgery》2023,115(1):88-95
BackgroundRecent guidelines for the treatment of moderate or severe ischemic mitral regurgitation (IMR) in patients undergoing coronary artery bypass grafting (CABG) have changed. This study assessed the real-world impact of changing guidelines on the management of IMR during CABG over time. We hypothesized that the utilization of mitral valve repair for IMR would decrease over time, whereas mitral valve replacement for severe IMR would increase.MethodsPatients undergoing CABG in a statewide collaborative database (2011-2020) were stratified by severity of IMR. Trends in mitral valve repair or replacement were evaluated. To account for differences of the patients, propensity score–matched analyses were used to compare patients with and without mitral intervention.ResultsA total of 11,676 patients met inclusion criteria, including 1355 (11.6%) with moderate IMR and 390 (3.3%) with severe IMR. The proportion of patients undergoing mitral intervention for moderate IMR decreased over time (2011, 17.7%; 2020, 7.5%; Ptrend = .001), whereas mitral replacement for severe IMR remained stable (2011, 11.1%; 2020, 13.3%; Ptrend = .14). Major morbidity was higher for patients with moderate IMR who underwent mitral intervention (29.1% vs 19.9%; P = .005). In a propensity analysis of 249 well-matched pairs, there was no difference in major morbidity (29.3% with mitral intervention vs 23.7% without; P = .16) or operative mortality (1.2% vs 2.4%; P = .5).ConclusionsConsistent with recent guideline updates, patients with moderate IMR were less likely to undergo mitral repair. However, the rate of replacement for severe IMR did not change. Mitral intervention during CABG did not increase operative mortality or morbidity. 相似文献
23.
《Saudi Pharmaceutical Journal》2022,30(8):1153-1158
BackgroundMigraine is one of the neurological diseases that have a negative impact on subjects’ productivity and daily activity of patients. Introducing monoclonal antibodies as a valuable option for resolving the persistent problem of migraine is still under investigation. The current study aimed to evaluate the efficacy and safety profile related to Erenumab.MethodsA prospective study for clinical data collection and analysis from recruited therapy-refractory migraine subjects were carried through 6 months for each subject. All subjects received Erenumab 70 mg monthly. Each patient provided the clinical data monthly starting from 0 months and for the next 6 months. Migraine disability assessment (MIDAS) questionnaire was used for evaluation of the Erenumab efficacy every 3 months. In addition, data regarding adverse effects, migraine triggers, and the impact of previous COVID-19 on migraine severity were collected and analyzed.ResultsNinety subjects were recruited in the study. Erenumab injections resulted in a significant (p < 0.001) reduction in MIDAS score in the 3rd month compared with baseline, also this significance was continuous in the 6th month. In contrast, there was no significant difference in the 6th month compared with the 3rd. Previously infected COVID-19 subjects showed a higher severity of migraine attacks compared with non-infected subjects. Skin redness and local pain were the most common adverse effects 63.3%, 47.77% respectively associated with Erenumab.ConclusionUsing Erenumab therapy showed a great beneficial impact regarding the reduction of migraine-related disabilities. COVID-19 was related to the increased severity of migraine attacks. 相似文献
24.
25.
26.
27.
28.
《Gait & posture》2022
ObjectiveThe aim of this study was to determine whether there is a difference in postural control between nulligravida women and women who have given birth by vaginal or cesarean section.MethodsWomen who had only vaginal delivery in the previous 1–3 years were included in the vaginal delivery group (n = 27), those who had only cesarean delivery in the previous 1–3 years were included in the cesarean section group (n = 28), and those who had never given birth were included in the control group (n = 32). Evaluations were administered 6–8 days after the ovulation phase. Postural control of the participants was evaluated with the computerized dynamic posturography device.ResultsA total of 87 women with a mean age of 29.4 ± 4 years and a mean body mass index of 24.1 ± 3.1 kg/m2 were included in the study. Antero-posterior somatosensory organization test values of the vaginal delivery group were lower than the control group (p = 0.0016). The cesarean delivery group had statistically lower antero-posterior somatosensory (p < 0.001 and p = 0.0013) and medio-lateral somatosensory (p = 0.002 and p = 0.017, respectively) test scores compared to the control group and the vaginal delivery group.ConclusionsIt was observed that women who birthed with vaginal or cesarean delivery had impaired somatosensory postural control. There is definitely a need for further studies with a long-term follow-up examining the effects of postural control during pregnancy and the postpartum period. 相似文献
29.
轻度认知障碍(Mild cognition impairment, MCI)是尚未达到阿尔兹海默病(Alzheimer’s disease, AD)的诊断标准且可逆转为正常脑老化状态的最佳窗口期。情志异常、肝失疏泄(肝失疏泄日久致肝郁)已被证实为MCI的重要情志病机,且“长期负性情绪积累肝失疏泄致衰加速脑老化”的科学假说已在本课题组前期研究中得到初步证实,疏肝法干预肝郁型MCI患者疗效显著,但以上作用机制尚未得到完全阐述。因此本研究系统总结了中医学对MCI的认识,长期情绪不调肝失疏泄对MCI的影响及可能机制,疏肝解郁方药及其成分改善肝郁型MCI的可行性,并提出使用无束缚性设计的眼动技术以探索疏肝法改善肝郁型MCI的可行性,为MCI的中医药干预及其神经机制探讨提供新思路,为中医情志衰老学说增添新内涵。 相似文献
30.
《台湾医志》2022,121(9):1864-1871